Cancerous diseases are the most serious public health problem, posing a significant clinical burden, disrupting societal standards, and draining vast amounts of financial resources. The study of the distribution and determinants of the likelihood of cancer development is known as cancer epidemiology. Cancer epidemiology can be used to find out what causes an increase or decrease in cancer incidence in a specific community. The aim is to discover causative factors in order to develop disease-prevention techniques. Epidemiologic assessment offers the doctor with a quantitative assessment of cancer risk, lays forth the foundation for high-risk population screening modalities, and assesses the success of any preventative intervention. A thorough understanding of cancer epidemiology gives crucial information on potential causes and population patterns, allowing for the development of timely and effective health-care interventions targeted at building effective policies for prevention, screening, and diagnosis.
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : Molecular-genetic study of low-grade and high-grade “basal-like” (triple-negative) breast carcinomas
Farid Moinfar, Ordensklinikum Linz Barmherzige Schwestern, Austria
Title : Updates on cancer research for detection and management
Patricia Tai, UpToDate, United States
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title : Altered expression of endoplasmic reticulum stress response genes and circular RNAs in oral squamous cell carcinoma tumorigenesis
Vandana Tiwari, Dr. Ram Manohar Lohia Institute of Medical Sciences, India